Laura Richert

Bordeaux Population Health, Université de Bordeaux

Papers

2

Total Citations

8

H-Index

2

About

Laura Richert is a leading researcher in urologic oncology, with a specialized focus on the clinical application of three-dimensional (3D) imaging and printing technologies for kidney cancer surgery. Her major contributions center on improving surgical outcomes and patient experience in robot-assisted partial nephrectomy (RAPN) for complex renal tumors. Richert is the principal investigator of the ACCURATE trial (UroCCR 99), a landmark randomized study evaluating 3D image-guided RAPN, and the Rein 3D Print Personalize trial (UroCCR 114), which investigates how personalized 3D-printed kidney models enhance patient understanding and caregiver communication before and after surgery. Her work demonstrates that these models serve as powerful educational tools, helping patients grasp their pathology and surgical anatomy, despite associated costs. With her most-cited papers from 2025 already accumulating citations, Richert’s research is rapidly shaping evidence-based practices in precision nephrectomy. Her achievements highlight a commitment to integrating cutting-edge visualization technology into routine clinical care, ultimately aiming to improve both surgical precision and the patient journey.

Research Focus

Key Achievements

2
H-Index
2
Papers
8
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Trial Protocol for ACCURATE: A CCafU-UroCCR Randomized Trial: Three-dimensional Image-guided Robot-assisted Partial Nephrectomy for Renal Complex Tumor (UroCCR 99)
5 citations · 2025
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Bordeaux Population Health, Université de Bordeaux

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago